Before initiating cetuximab therapy, the provider will order epidermal growth factor receptor (EGFR) testing for the patient having which condition?

Question

Quizplus · Accepted Answer

Cetuximab is a monoclonal antibody used in the treatment of metastatic colorectal cancer and head and neck cancer. It targets the epidermal growth factor receptor (EGFR), which is often overexpressed in these cancers. Testing for EGFR expression is crucial in colorectal cancer to determine the likelihood of response to cetuximab therapy.

Before Initiating Cetuximab Therapy, the Provider Will Order Epidermal Growth